{"id":15775,"date":"2023-02-03T14:00:00","date_gmt":"2023-02-03T14:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4005027_AE05027_0"},"modified":"2023-02-03T14:00:00","modified_gmt":"2023-02-03T14:00:00","slug":"treadwell-therapeutics-announces-the-appointment-of-roger-sidhu-m-d-as-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=15775","title":{"rendered":"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" class=\"ff-og-image-inserted\"><\/div>\n<p><span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">Feb. 3, 2023<\/span> \/PRNewswire\/ &#8212; Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first in class therapeutics for highly aggressive cancers, today announced that it has appointed <span class=\"xn-person\">Roger Sidhu<\/span>, M.D., as Chief Medical Officer. Dr. Sidhu is a seasoned leader and brings to <span class=\"xn-location\">Treadwell<\/span> an extensive track record of success over the last 15 years in hematologic and solid tumor oncology research and development with&nbsp;deep translational, clinical and regulatory experience across multiple therapeutic modalities and platforms including small molecules, biologics and cell and gene therapies. &nbsp;&nbsp;<\/p>\n<p>&#8220;We are excited to welcome Dr. Sidhu to our team as we further the development of our small molecule, biologic and cell therapy pipeline,&#8221; said Dr. <span class=\"xn-person\">Michael Tusche<\/span>, <span class=\"xn-location\">Treadwell<\/span> co-CEO. &#8220;Roger has an extensive track record of success in all aspects of drug development from early to late stage through regulatory approval, as well as being a proven leader and builder.&nbsp; His expertise will be invaluable to our mission of translating novel scientific ideas into first in class medicines for patients in need.&#8221;<\/p>\n<p>&#8220;<span class=\"xn-location\">Treadwell&#8217;s<\/span> innovative, first in class pipeline against novel targets in hematologic and solid tumors is driven by world class science and positions the company at the forefront of the next generation of personalized medicines,&#8221; said Dr. Sidhu. &#8220;I am excited to join the world class team at <span class=\"xn-location\">Treadwell<\/span> and advance the mission of delivering new medicines for patients with high unmet need in cancer globally.&#8221;<\/p>\n<p>Dr. Sidhu was most recently the Chief Medical Officer at <span class=\"xn-location\">Brooklyn<\/span> (now Eterna) ImmunoTherapeutics, a gene editing and cell therapy company where he advanced multiple novel programs. Previously, Dr. Sidhu served as Executive Vice President and Chief Medical officer at Roivant Sciences. Roger was also the Chief Medical Officer at Cell Design Labs, up until its acquisition by the Gilead subsidiary Kite, where he subsequently served as VP, Clinical Development. Dr. Sidhu also held various roles of increasing responsibility at Amgen where he was an Executive Medical Director in the Hematology\/Oncology Therapeutic area with responsibilities that included advancing preclinical and clinical candidates through registration globally. Dr. Sidhu is a Fellow of the Royal College of Physicians and Surgeons of <span class=\"xn-location\">Canada<\/span> in both internal medicine and medical oncology. He earned his medical degree from Queen&#8217;s University in <span class=\"xn-location\">Kingston, Ontario Canada<\/span> and his Bachelor&#8217;s degree in biochemistry from the <span class=\"xn-org\">University of Alberta<\/span> in <span class=\"xn-location\">Edmonton, Alberta<\/span>. Dr. Sidhu trained in internal medicine at Queen&#8217;s University and medical oncology at the British Columbia Cancer Agency in <span class=\"xn-location\">Vancouver, British Columbia<\/span> and the Cross Cancer Institute in <span class=\"xn-location\">Edmonton, Alberta<\/span>.<\/p>\n<p><b>About Treadwell Therapeutics<\/b><\/p>\n<p>Treadwell Therapeutics is a science driven, clinical-stage, multi-modality biotechnology company developing first-in-class and best-in-class medicines to address unmet needs in patients with cancer.&nbsp; The Company&#8217;s internally developed small molecule clinical pipeline includes CFI-400945 (PLK4 inhibitor), CFI-402257 (TTK inhibitor) and CFI-402411 (HPK1 inhibitor).&nbsp; The company is also advancing a pre-clinical pipeline of first-in-class antibody and TCR-based cell therapy assets. For more information, please visit <a href=\"http:\/\/www.treadwelltx.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.treadwelltx.com<\/a>.<\/p>\n<p><b>Contact<\/b><br \/><a href=\"mailto:ir@treadwelltx.com\" target=\"_blank\" rel=\"nofollow noopener\">ir@treadwelltx.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 3, 2023 \/PRNewswire\/ &#8212; Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first in class therapeutics for highly aggressive cancers, today announced that it has appointed Roger Sidhu, M.D., as Chief Medical Officer. Dr. Sidhu is a seasoned leader and brings to Treadwell an extensive track record of success over the [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-15775","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=15775\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer - My Blog\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 3, 2023 \/PRNewswire\/ &#8212; Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first in class therapeutics for highly aggressive cancers, today announced that it has appointed Roger Sidhu, M.D., as Chief Medical Officer. Dr. Sidhu is a seasoned leader and brings to Treadwell an extensive track record of success over the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=15775\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-03T14:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer\",\"datePublished\":\"2023-02-03T14:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775\"},\"wordCount\":512,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775\",\"name\":\"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"datePublished\":\"2023-02-03T14:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775#primaryimage\",\"url\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"contentUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15775#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=15775","og_locale":"en_US","og_type":"article","og_title":"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer - My Blog","og_description":"NEW YORK, Feb. 3, 2023 \/PRNewswire\/ &#8212; Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first in class therapeutics for highly aggressive cancers, today announced that it has appointed Roger Sidhu, M.D., as Chief Medical Officer. Dr. Sidhu is a seasoned leader and brings to Treadwell an extensive track record of success over the [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=15775","og_site_name":"My Blog","article_published_time":"2023-02-03T14:00:00+00:00","og_image":[{"url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=15775#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15775"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer","datePublished":"2023-02-03T14:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15775"},"wordCount":512,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15775#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=15775","url":"https:\/\/transmediavictoria.net.au\/?p=15775","name":"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15775#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15775#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","datePublished":"2023-02-03T14:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15775#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=15775"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=15775#primaryimage","url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","contentUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=15775#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/15775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15775"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/15775\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}